Abstract
Renal parenchymal disease (RPD) is classified into glomerular, tubular, interstitial, and vascular disease. These various diseases may be congenital (hereditary) or acquired. They exclusively may affect the kidneys or are systemic disorders with a wide range of renal contribution. This chapter focuses on the “classic entities” of RPD like glomerulonephritis (GN) or nephrotic syndrome (NS) showing clinical presentation, pathogenesis, renal histology if renal biopsy is indicated, treatment, and prognosis of the various diseases. References are restricted to important new publications where the interested reader can also find suggestions for further reading. The implications for imaging including ultrasound-guided renal biopsy are described in chapter “Imaging in Renal Parenchymal Disease”.
References
Akchurin O, Reidy KJ (2015) Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology. Pediatr Nephrol 30:221–233
Alchi B, Jayne D (2010) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25:1409–1418
Alchi B, Griffiths M, Jayne D (2010) What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 25:3147–3154
Ayalon R, Beck LH Jr (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31–39
Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8–11
Barbour TD, Pickering MC, Cook HT (2013) Dense deposit disease and C3 glomerulopathy. Semin Nephrol 33:493–507
Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–12
Becker AM (2011) Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol 26:2099–2109
Berger J, Hinglais N (1968) Les dépôts intercapillaires d’IgA-IgG. J Urol Neprol 74:694–695
Berman H, Rodriguez-Pinto I, Cervera R et al (2014) Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry”. Autoimmun Rev 13:157–162
Besbas N, Karpman D, Landau D et al (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423–431
Bomback AS, Smith RJ, Barile GR et al (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748–756
Brogan P, Eleftheriou D, Dillon M (2010) Small vessel vasculitis. Pediatr Nephrol 25:1025–1035
Cakar N, Özcakar ZB, Soy D et al (2008) Renal involvement in childhood vasculitis. Nephron Clin Pract 108:c202
Cara-Fuentes G, Wei C, Segarra A et al (2014) CD80 and suPAR in patients with minimal change disease and focal glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol 29:1363–1371
Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545
Coppo R, Troyanov S, Camilla R et al (2010) The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 77:921–927
Dallas MH, Triplett B, Shook DR et al (2013) Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 19:820–830
Debiec H, Lefeu F, Kemper MJ et al (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101–2110
Delmas Y, Vendrely B, Clouzeau B et al (2014) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565–572
Dillon MJ, Eleftheriou D, Brogan PA (2010) Medium-size-vessel vasculitis. Pediatr Nephrol 25:1641–1652
Edvardsson VO, Goldfarb DS, Lieske JC et al (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28:1923–1942
Eison TM, Ault BH, Jones DP et al (2011) Post-streptococcal glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol 26:165–180
Eleftheriou D, Brogan PA (2009) Vasculitis in children. Best Pract Res Clin Rheumatol 23:309–323
Emma F, Nesterova G, Langman C et al (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29:iv87–iv94
Gauthier B, Trachtman H, Frank R et al (1989) Familial thin basement membrane nephropathy in children with asymptomatic microhematuria. Nephron 51:502–508
Gbadegesin R, Winn M, Smoyer WE (2013) Genetic testing in nephrotic syndrome: challenges and opportunities. Nat Rev Nephrol 9:179–184
Gellermann J, Weber L, Pape L et al (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689–1697
Gutierrez E, Zamora I, Ballarin JA et al (2012) Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23:1753–1760
Hinkes BG, Mucha B, Vlangos CN et al (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–e919
Hochberg MC (1997) Updating the American College of Rheumatology revisited criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Houssiau FA, Vasconcelos D, D’Cruz D et al (2012) The 10-year follow-up data of the Euro-Lupus Nepritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 69:61–64
Huang E, Parke C, Mehrnia A et al (2013) Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrol Dial Transplant 28:1039–1046
Ishikura K, Hamasaki Y, Sakai T et al (2012) Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 27:375–384
Jahnukainen T, Ala-Houala M, Karikoski R et al (2011) Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol 26:291–299
Jais JP, Knebelmann B, Giatras I et al (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol 14:2603–2610
Jodele S, Fukuda T, Vinks A et al (2014) Eculizumab therapy in children with severe hematopoietic stem cell transplantation-assiciated thrombotic microangiopathy. Biol Blood Marrow Transplant 20:518–525
Joss N, Morris S, Young B et al (2007) Granulomatous interstitial nephritis. Clin J Am Soc Nephrol 2:222–230
Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10:651–657
Kestilä M, Lenkkeri U, Männikkö M et al (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582
Koehler H, Wandel E, Brunck N (1991) Acanthocyturia – A characteristic marker for glomerular bleeding. Kidney Int 40:115–120
Korkmaz C (2012) Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine. Clin Exp Rheumatol 30(Suppl 72):S104–S107
Krug P, Boyer O, Balzamo E et al (2012) Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol 27:1547–1550
Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430
Loirat C, Frémeaux-Bacci V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60
Lombel RM, Gipson DS, Hodson EM (2013a) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415–426
Lombel RM, Hodson EM, Gipson DS (2013b) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:409–414
Lutalo PM, D’Cruz DP (2014) Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun 48–49:94–98
Mache CJ, Schwingshandl J, Riccabona M et al (1993) Ultrasound and MRI findings in a case of childhood amyloid goiter. Pediatr Radiol 23:565–566
Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V et al (2009) Complement inhibitor Eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312.1316
Malina M, Gulati A, Bagga A et al (2013) Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131:e331–e335
McKie KT, Hanevold CD, Hernandez C et al (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140–144
Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25:1419–1428
Murakami M, Yamamoto H, Ueda Y et al (1991) Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol 5:50–53
Nesterova G, Gahl WA (2013) Cystinosis: the evolution of a treatable disease. Pediatr Nephrol 28:51–59
Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050
Ozen S, Pistorio A, Iusan MS et al (2009) The EULAR/PRINTO/PRES criteria for childhood polyarteritis nodosa. Ankara 2008. Ann Rheum Dis 68(Suppl 3):713
Park YH, Choi JY, Chung HS et al (2005) Hematuria and proteinuria in a mass school screening test. Pediatr Nephrol 20:1126–1130
Pohl M (2015) Henoch-Schönlein purpura nephritis. Pediatr Nephrol 30:245–252
Pozzi C, Andrulli S, Del Veccio L et al (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163
Punaro MG (2013) The treatment of systemic lupus proliferative nephritis. Pediatr Nephrol 28:2069–2078
Radhakrishnan S, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient. Kidney Int 82:840–856
Radhakrishnan S, Lunn A, Kirschfink M et al (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165–1166
Rana K, Wang YY, Buzza M et al (2005) The genetics of thin basement membrane nephropathy. Semin Nephrol 25:163–170
Rosales A, Hofer J, Zimmerhackl LB et al (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Inf Dis 54:1413–1421
Savige J, Gregory M, Gross O et al (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364–375
Sethi S, Fervenza FC (2011) Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31:341–348
Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis – a new look at an old entity. N Engl J Med 366:1119–1131
Seyberth HW, Schlingmann KP (2011) Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 26:1789–1802
Sharpe CC, Thein SL (2011) Sickle cell nephropathy – a practical approach. Br J Haematol 155:287–297
Shenoy M, Plant ND, Lewis MA et al (2010) Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 25:899–903
Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232
Szugye HS, Zeft AS, Spalding SJ (2014) Takayasu arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatric Rheumatology 12:21
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086
Town M, Jean G, Cherqui S et al (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet 18:319–324
Tullus M (2012) New developments in the treatment of systemic lupus erythematosus. Pediatr Nephrol 27:727–732
Van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26:881–892
Vehaskari VM, Rapola J (1982) Isolated Proteinuria: analysis of a school-age population. J Pediatr 101:661–668
Vehaskari VM, Rapola J, Koskimies O et al (1979) Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr 95:676–684
Vester U, Mache CJ (2014) Pharmacologic treatment of atypical hemolytic-uremic syndrome. Exp Opin Orphan Drugs 2:123–135
Watanabe T (2013) Kidney and urinary tract involvement in Kawasaki disease. Int J Pediatr Article ID 831834
Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414
Zand L, Specks U, Sethi S et al (2014) Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Adv Chronic Kidney Dis 21:182–193
Zuber J, Fakhouri F, Roumenina LT et al (2012) Use of eculizumab for atypical hemolytic uremic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643–657
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ring, E., Acham-Roschitz, B. (2018). Renal Parenchymal Disease. In: Riccabona, M. (eds) Pediatric Urogenital Radiology. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-319-39202-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-39202-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39200-4
Online ISBN: 978-3-319-39202-8
eBook Packages: MedicineMedicine (R0)